<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/">
  <channel>
    <title>Alex Garcia - Seeking Alpha</title>
    <description>'Alex Garcia' Tag RSS Syndication from SeekingAlpha.com</description>
    <author>
      <name>SeekingAlpha.com</name>
    </author>
    <link>http://seekingalpha.com/author/alex-garcia</link>
    <item>
      <title>Secret to Value Investing: Ignore Market Noise</title>
      <link>http://seekingalpha.com/article/61736-secret-to-value-investing-ignore-market-noise?source=feed</link>
      <guid isPermaLink="false">61736</guid>
      <content>
        <![CDATA[<p>Have you ever wondered what separates David Dreman, Warren Buffett,
Charlie Munger, etc. from the rest of the world?<!--more--> The answer is simple, but
the force behind it can make the difference between a great investor
and an average investor. I am talking about investor psychology, also
known as Behavior Finance.<span id="more-14"></span></p>
<p>One can learn value investing by picking up a couple of books,
attending a couple of seminars, etc. but all that is useless if you let
emotions interfere with your decision making process. In the preface to
the 4th edition of Benjamin Graham’s <em>The Intelligent Investor, </em>Warren Buffett had this to say about successful investing:</p>]]>
      </content>
      <pubDate>Sun, 27 Jan 2008 07:48:35 -0500</pubDate>
      <author>Alex Garcia</author>
      <description>
        <![CDATA[strong><a href="http://wslounge.com/">Alex Garcia</a> submits: </strong><p>Have you ever wondered what separates David Dreman, Warren Buffett,
Charlie Munger, etc. from the rest of the world?<!--more--> The answer is simple, but
the force behind it can make the difference between a great investor
and an average investor. I am talking about investor psychology, also
known as Behavior Finance.<span id="more-14"></span></p>
<p>One can learn value investing by picking up a couple of books,
attending a couple of seminars, etc. but all that is useless if you let
emotions interfere with your decision making process. In the preface to
the 4th edition of Benjamin Graham’s <em>The Intelligent Investor, </em>Warren Buffett had this to say about successful investing:</p><br/><a href='http://seekingalpha.com/article/61736-secret-to-value-investing-ignore-market-noise?source=feed'>Complete Story &raquo;</a>]]>
      </description>
      <category type="author" link="http://seekingalpha.com/author/alex-garcia">Alex Garcia</category>
    </item>
    <item>
      <title>United Rentals Currently Offers a Margin of Safety</title>
      <link>http://seekingalpha.com/article/61102-united-rentals-currently-offers-a-margin-of-safety?source=feed</link>
      <guid isPermaLink="false">61102</guid>
      <content>
        <![CDATA[<p>
It is amazing what a volatile market can do. As I experience my first market correction of my short investing career, everything that I have read has prepared me in finding the bargains.<!--more--> The big financials are the obvious choices but finding a small well-run company is where the big money is made. I could sit here and write several articles on big banks but that is not why I set up this blog for in the first place. I wanted to find small caps that would outperform the market in the long run. Lately, I have hit the books and came out with a big catch. United Rentals (URI) is the name and value is the game.</p> <p><strong>Business Profile from <a href=" http://finance.yahoo.com/q/pr?s=URI" target="_blank">Yahoo Finance </a></strong></p>]]>
      </content>
      <pubDate>Tue, 22 Jan 2008 18:20:30 -0500</pubDate>
      <author>Alex Garcia</author>
      <description>
        <![CDATA[strong><a href="http://wslounge.com/">Alex Garcia</a> submits: </strong><p>
It is amazing what a volatile market can do. As I experience my first market correction of my short investing career, everything that I have read has prepared me in finding the bargains.<!--more--> The big financials are the obvious choices but finding a small well-run company is where the big money is made. I could sit here and write several articles on big banks but that is not why I set up this blog for in the first place. I wanted to find small caps that would outperform the market in the long run. Lately, I have hit the books and came out with a big catch. United Rentals (URI) is the name and value is the game.</p> <p><strong>Business Profile from <a href=" http://finance.yahoo.com/q/pr?s=URI" target="_blank">Yahoo Finance </a></strong></p><br/><a href='http://seekingalpha.com/article/61102-united-rentals-currently-offers-a-margin-of-safety?source=feed'>Complete Story &raquo;</a>]]>
      </description>
      <category type="symbol" link="http://seekingalpha.com/symbol/uri">URI</category>
      <category type="author" link="http://seekingalpha.com/author/alex-garcia">Alex Garcia</category>
    </item>
    <item>
      <title>Vineyard National Bancorp: All The Characteristics of a Contrarian Play</title>
      <link>http://seekingalpha.com/article/59903-vineyard-national-bancorp-all-the-characteristics-of-a-contrarian-play?source=feed</link>
      <guid isPermaLink="false">59903</guid>
      <content>
        <![CDATA[<p>It has been a while since I have done security analysis on a stock with a
market cap of this size. <!--more-->Currently, Mr. Market is valuing Vineyard National
Bancorp (VNBC) at less than $100 million. The million dollar
question is whether Vineyard warrants this type of valuation. As
Buffett has said, “Price is what you pay, Value is what you
get.”</p>
<p><strong> The Business</strong></p>]]>
      </content>
      <pubDate>Sun, 13 Jan 2008 05:25:55 -0500</pubDate>
      <author>Alex Garcia</author>
      <description>
        <![CDATA[strong><a href="http://wslounge.com/">Alex Garcia</a> submits: </strong><p>It has been a while since I have done security analysis on a stock with a
market cap of this size. <!--more-->Currently, Mr. Market is valuing Vineyard National
Bancorp (VNBC) at less than $100 million. The million dollar
question is whether Vineyard warrants this type of valuation. As
Buffett has said, “Price is what you pay, Value is what you
get.”</p>
<p><strong> The Business</strong></p><br/><a href='http://seekingalpha.com/article/59903-vineyard-national-bancorp-all-the-characteristics-of-a-contrarian-play?source=feed'>Complete Story &raquo;</a>]]>
      </description>
      <category type="symbol" link="http://seekingalpha.com/symbol/vnbc">VNBC</category>
      <category type="author" link="http://seekingalpha.com/author/alex-garcia">Alex Garcia</category>
    </item>
    <item>
      <title>5 Magic Formula Stock Picks for 2008</title>
      <link>http://seekingalpha.com/article/59892-5-magic-formula-stock-picks-for-2008?source=feed</link>
      <guid isPermaLink="false">59892</guid>
      <content>
        <![CDATA[<p> The following five companies appeared using a minimum market
capitalization of 256 million returning 100 stocks.<!--more--> All five companies
have pretax earnings yield of at least 10% and high pretax return on
capital.</p>

<p>
<img src="http://static.seekingalpha.com/uploads/2008/1/13/acn.gif" style="float: right; margin-left: 5px" />
</p>]]>
      </content>
      <pubDate>Sun, 13 Jan 2008 04:41:37 -0500</pubDate>
      <author>Alex Garcia</author>
      <description>
        <![CDATA[strong><a href="http://wslounge.com/">Alex Garcia</a> submits: </strong><p> The following five companies appeared using a minimum market
capitalization of 256 million returning 100 stocks.<!--more--> All five companies
have pretax earnings yield of at least 10% and high pretax return on
capital.</p>

<p>
<img src="http://static.seekingalpha.com/uploads/2008/1/13/acn.gif" style="float: right; margin-left: 5px" />
</p><br/><a href='http://seekingalpha.com/article/59892-5-magic-formula-stock-picks-for-2008?source=feed'>Complete Story &raquo;</a>]]>
      </description>
      <category type="symbol" link="http://seekingalpha.com/symbol/acn">ACN</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/aeo">AEO</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/jtx">JTX</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/mhp">MHP</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/pacr">PACR</category>
      <category type="author" link="http://seekingalpha.com/author/alex-garcia">Alex Garcia</category>
    </item>
    <item>
      <title>A Glance At US Bancorp and Homebuilder Stocks</title>
      <link>http://seekingalpha.com/article/43607-a-glance-at-us-bancorp-and-homebuilder-stocks?source=feed</link>
      <guid isPermaLink="false">43607</guid>
      <content>
        <![CDATA[Wow, what a market. On July 19 we saw the Dow Jones Industrials hit 14,000 and everyone expected it to race to 15,000. Sub prime and credit worries have now interrupted the rally putting the DJIA about 6% off its highs.<!--more-->
</p>
<p><strong>Financials</strong>
</p>]]>
      </content>
      <pubDate>Mon, 06 Aug 2007 08:18:26 -0400</pubDate>
      <author>Alex Garcia</author>
      <description>
        <![CDATA[strong><a href="http://wslounge.com/">Alex Garcia</a> submits: </strong>Wow, what a market. On July 19 we saw the Dow Jones Industrials hit 14,000 and everyone expected it to race to 15,000. Sub prime and credit worries have now interrupted the rally putting the DJIA about 6% off its highs.<!--more-->
</p>
<p><strong>Financials</strong>
</p><br/><a href='http://seekingalpha.com/article/43607-a-glance-at-us-bancorp-and-homebuilder-stocks?source=feed'>Complete Story &raquo;</a>]]>
      </description>
      <category type="symbol" link="http://seekingalpha.com/symbol/usb">USB</category>
      <category type="author" link="http://seekingalpha.com/author/alex-garcia">Alex Garcia</category>
    </item>
    <item>
      <title>Four Attractive Money Center Banks</title>
      <link>http://seekingalpha.com/article/39872-four-attractive-money-center-banks?source=feed</link>
      <guid isPermaLink="false">39872</guid>
      <content>
        <![CDATA[With stocks like Research In Motion (RIMM), Apple (AAPL), Amazon (AMZN) and Google (GOOG) soaring, I have found great value in the financial sector, specifically money center banks where multiples are at historically low levels and yields are attractive.<!--more-->

<p><center><img title="banks" src="http://static.seekingalpha.com/wp-content/seekingalpha/images/banks.jpg" border="0" height="150" alt="banks" width="350" /></center>*considered an S&L
</p>
<p><strong>Bank of America</strong> (BAC) has never been one of my favorite banks, but with fundamentals like these, it became hard to keep off the list.
</p>]]>
      </content>
      <pubDate>Mon, 02 Jul 2007 05:04:19 -0400</pubDate>
      <author>Alex Garcia</author>
      <description>
        <![CDATA[strong><a href="http://wslounge.com/">Alex Garcia</a> submits: </strong>With stocks like Research In Motion (RIMM), Apple (AAPL), Amazon (AMZN) and Google (GOOG) soaring, I have found great value in the financial sector, specifically money center banks where multiples are at historically low levels and yields are attractive.<!--more-->

<p><center><img title="banks" src="http://static.seekingalpha.com/wp-content/seekingalpha/images/banks.jpg" border="0" height="150" alt="banks" width="350" /></center>*considered an S&L
</p>
<p><strong>Bank of America</strong> (BAC) has never been one of my favorite banks, but with fundamentals like these, it became hard to keep off the list.
</p><br/><a href='http://seekingalpha.com/article/39872-four-attractive-money-center-banks?source=feed'>Complete Story &raquo;</a>]]>
      </description>
      <category type="symbol" link="http://seekingalpha.com/symbol/bac">BAC</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/c">C</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/wfc">WFC</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/wm">WM</category>
      <category type="author" link="http://seekingalpha.com/author/alex-garcia">Alex Garcia</category>
    </item>
    <item>
      <title>Is Rupert Murdoch Overpaying For Dow Jones?</title>
      <link>http://seekingalpha.com/article/38477-is-rupert-murdoch-overpaying-for-dow-jones?source=feed</link>
      <guid isPermaLink="false">38477</guid>
      <content>
        <![CDATA[While the market debates which way it wants to go, one thing is for certain, M&A activity has slowed down these past couple of weeks. It became routine to turn on the television and see company “X” has taken over company “Y”. But the offer I am keeping a close eye on is Rupert Murdoch’s News Corp’s (NWS) 5 billion dollar <a href="http://biz.yahoo.com/ap/070501/news_corp_dow_jones.html?.v=25">bid</a> for Dow Jones (DJ).<!--more-->
</p>
<p>The debate that is going on in my mind is whether Murdoch is overpaying for Dow Jones. The first thought that came to mind when I heard the offer on television was a) Murdoch is paying too high of a premium b) investment return on Dow Jones’s newspaper assets (Wall Street Journal and Barron's) are sure to decline as time passes. 
</p>]]>
      </content>
      <pubDate>Fri, 15 Jun 2007 09:17:35 -0400</pubDate>
      <author>Alex Garcia</author>
      <description>
        <![CDATA[strong><a href="http://wslounge.com/">Alex Garcia</a> submits: </strong>While the market debates which way it wants to go, one thing is for certain, M&A activity has slowed down these past couple of weeks. It became routine to turn on the television and see company “X” has taken over company “Y”. But the offer I am keeping a close eye on is Rupert Murdoch’s News Corp’s (NWS) 5 billion dollar <a href="http://biz.yahoo.com/ap/070501/news_corp_dow_jones.html?.v=25">bid</a> for Dow Jones (DJ).<!--more-->
</p>
<p>The debate that is going on in my mind is whether Murdoch is overpaying for Dow Jones. The first thought that came to mind when I heard the offer on television was a) Murdoch is paying too high of a premium b) investment return on Dow Jones’s newspaper assets (Wall Street Journal and Barron's) are sure to decline as time passes. 
</p><br/><a href='http://seekingalpha.com/article/38477-is-rupert-murdoch-overpaying-for-dow-jones?source=feed'>Complete Story &raquo;</a>]]>
      </description>
      <category type="symbol" link="http://seekingalpha.com/symbol/dj">DJ</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/nws">NWS</category>
      <category type="author" link="http://seekingalpha.com/author/alex-garcia">Alex Garcia</category>
    </item>
    <item>
      <title>Amgen&#8217;s Story Gets Better And Better</title>
      <link>http://seekingalpha.com/article/37583-amgens-story-gets-better-and-better?source=feed</link>
      <guid isPermaLink="false">37583</guid>
      <content>
        <![CDATA[It has been almost two weeks since <a href="http://biotech.seekingalpha.com/article/36568">I wrote</a> about Amgen (AMGN) being a bargain. Since then, the story has only improved for Amgen and its shareholders.<!--more-->
</p>
<p>Since the first posting, Amgen has agreed to acquire two privately held bio-tech companies using cash. On the 4th of June, Amgen <a href="http://yahoo.reuters.com/news/articlehybrid.aspx?storyID=urn:newsml:reuters.com:20070604:MTFH38745_2007-06-04_21-47-53_N64197755&type=comktNews&rpc=44">agreed to buy</a> Santa Clara based Ilypsa for $420 million in cash. The acquisition adds Ilypsa’s main product, Ily101, which is designed to treat hyperphosphatemia in chronic kidney disease in patients on hemodialysis to Amgen’s already strong pipeline. 
</p>]]>
      </content>
      <pubDate>Thu, 07 Jun 2007 02:46:12 -0400</pubDate>
      <author>Alex Garcia</author>
      <description>
        <![CDATA[strong><a href="http://wslounge.com/">Alex Garcia</a> submits: </strong>It has been almost two weeks since <a href="http://biotech.seekingalpha.com/article/36568">I wrote</a> about Amgen (AMGN) being a bargain. Since then, the story has only improved for Amgen and its shareholders.<!--more-->
</p>
<p>Since the first posting, Amgen has agreed to acquire two privately held bio-tech companies using cash. On the 4th of June, Amgen <a href="http://yahoo.reuters.com/news/articlehybrid.aspx?storyID=urn:newsml:reuters.com:20070604:MTFH38745_2007-06-04_21-47-53_N64197755&type=comktNews&rpc=44">agreed to buy</a> Santa Clara based Ilypsa for $420 million in cash. The acquisition adds Ilypsa’s main product, Ily101, which is designed to treat hyperphosphatemia in chronic kidney disease in patients on hemodialysis to Amgen’s already strong pipeline. 
</p><br/><a href='http://seekingalpha.com/article/37583-amgens-story-gets-better-and-better?source=feed'>Complete Story &raquo;</a>]]>
      </description>
      <category type="symbol" link="http://seekingalpha.com/symbol/amgn">AMGN</category>
      <category type="author" link="http://seekingalpha.com/author/alex-garcia">Alex Garcia</category>
    </item>
    <item>
      <title>Amgen: Still A Bargain Despite New Warning Labels</title>
      <link>http://seekingalpha.com/article/36568-amgen-still-a-bargain-despite-new-warning-labels?source=feed</link>
      <guid isPermaLink="false">36568</guid>
      <content>
        <![CDATA[An FDA panel recommended stronger warning labels and further clinical studies on Amgen’s (AMGN) Arenesp drug and Johnson and Johnson’s (JNJ) Procrit drugs. In typical Wall Street fashion, shares of Amgen sold off on the recommendations.<!--more--> 

<p>The clinical studies and new warning labels are sure to impact Amgen’s top and bottom line. The question is how much impact? Analysts and sometimes the panel seemed confused about the whole situation. According to <a href="http://www.forbes.com/2007/05/11/amgen-fda-update-markets-equity-cx_er_0511markets19.html?partner=yahootix">Forbes.com</a>, the panel asked several times “what was the question?” and the questions themselves were “vague.” The shares of Amgen have now become very attractive despite the recent selloff.
</p>
<p>Amgen Inc., a biotechnology company, engages in the discovery, development, manufacture, and marketing of human therapeutics based on advances in cellular and molecular biology. It markets human therapeutic products in the areas of supportive cancer care, nephrology, inflammation, and oncology worldwide. 
</p>]]>
      </content>
      <pubDate>Tue, 29 May 2007 07:47:09 -0400</pubDate>
      <author>Alex Garcia</author>
      <description>
        <![CDATA[strong><a href="http://wslounge.com/">Alex Garcia</a> submits: </strong>An FDA panel recommended stronger warning labels and further clinical studies on Amgen’s (AMGN) Arenesp drug and Johnson and Johnson’s (JNJ) Procrit drugs. In typical Wall Street fashion, shares of Amgen sold off on the recommendations.<!--more--> 

<p>The clinical studies and new warning labels are sure to impact Amgen’s top and bottom line. The question is how much impact? Analysts and sometimes the panel seemed confused about the whole situation. According to <a href="http://www.forbes.com/2007/05/11/amgen-fda-update-markets-equity-cx_er_0511markets19.html?partner=yahootix">Forbes.com</a>, the panel asked several times “what was the question?” and the questions themselves were “vague.” The shares of Amgen have now become very attractive despite the recent selloff.
</p>
<p>Amgen Inc., a biotechnology company, engages in the discovery, development, manufacture, and marketing of human therapeutics based on advances in cellular and molecular biology. It markets human therapeutic products in the areas of supportive cancer care, nephrology, inflammation, and oncology worldwide. 
</p><br/><a href='http://seekingalpha.com/article/36568-amgen-still-a-bargain-despite-new-warning-labels?source=feed'>Complete Story &raquo;</a>]]>
      </description>
      <category type="symbol" link="http://seekingalpha.com/symbol/amgn">AMGN</category>
      <category type="author" link="http://seekingalpha.com/author/alex-garcia">Alex Garcia</category>
    </item>
    <item>
      <title>Amgen: Still a Bargain Despite Recent Selloff </title>
      <link>http://seekingalpha.com/article/35402-amgen-still-a-bargain-despite-recent-selloff?source=feed</link>
      <guid isPermaLink="false">35402</guid>
      <content>
        <![CDATA[An FDA panel recommended stronger warning labels and further clinical studies on Amgen's (AMGN) Arenesp drug and Johnson and Johnson's (JNJ) Procrit drugs. <!--more-->In typical Wall Street fashion, shares of Amgen sold off on the recommendations. The clinical studies and new warning labels are sure to have impact on Amgen's top and bottom line. The question is how much impact? Analysts and sometimes the panel seemed confused about the whole situation. According to <a href="http://www.forbes.com/2007/05/11/amgen-fda-update-markets-equity-cx_er_0511markets19.html?partner=yahootix ">Forbes.com</a>, the panel asked several times "what was the question?" and the questions themselves were "vague". The shares of Amgen have now become very attractive despite the recent selloff.
<br />
<a href="http://finance.yahoo.com/q/pr?s=AMGN ">
<br />
Amgen Inc.</a>, a biotechnology company, engages in the discovery, development, manufacture, and marketing of human therapeutics based on advances in cellular and molecular biology. It markets human therapeutic products in the areas of supportive cancer care, nephrology, inflammation, and oncology worldwide. The company's principal products include Aranesp and EPOGEN that stimulate the production of red blood cells to treat anemia; Neulasta and NEUPOGEN, which selectively stimulate the production of neutrophils, a type of white blood cell that helps the body fight infections; ENBREL that blocks the biologic activity of tumor necrosis factor by inhibiting TNF, a substance induced in response to inflammatory and immunological responses, such as rheumatoid arthritis and psoriasis; Vectibix, which binds specifically to the human epidermal growth factor receptor and interferes with signals that stimulate growth and survival of the cancer cell; and Sensipar for treating chronic kidney disease patients on dialysis. Amgen has a joint venture with Kirin Brewery Company, Limited (KNBWY.PK), for the development and commercialization of products based on advanced biotechnology, as well as a co-promotion agreement with Wyeth (WYE) related to the manufacture, supply, inventory, and allocation of bulk supplies of ENBREL. The company also entered into a collaboration agreement with Cytokinetics, Inc. (CYTK) to discover, develop, and commercialize novel small-molecule therapeutics that activate cardiac muscle contractility for potential applications in the treatment of heart failure. Amgen, Inc. was founded in 1980 and is based in Thousand Oaks, California.  

<p>When evaluating a biotech company, one has to pay special attention to Research and Development (R&D) and its pipeline. According to its <a href="http://yahoo.brand.edgar-online.com/fetchFilingFrameset.aspx?dcn=0001193125-07-042586&Type=HTML ">recent annual report</a>, Amgen spent 3.36 billion on R&D, compared to 2.314 billion the prior year. The bears will argue that Amgen's pipeline is dry. But that argument is as old as the hills. Amgen's pipeline is one of the strongest, if not the strongest in the industry. Using three years of clinical data, Amgen plans to file for FDA approval in 2008 for denosumab in osteoporosis (Phase III).Denosumab will be the premier osteoporosis drug in the market once it is approved. Amgen is also on track to file for AMG 531 (Phase III), the treatment of immune thrombocytopenic purpura (a rare bleeding disorder). The filing is set for this year.In addition, A Phase III trial to prolong survival in prostate cancer patients whose cancer has spread to the bones during treatment is also ongoing.
</p>
<p>Lazard Capital analyst, Joel Sendek <a href="http://www.forbes.com/2007/05/11/amgen-fda-update-markets-equity-cx_er_0511markets19.html?partner=yahootix ">lowered 2007's EPS estimates</a> from 4.30 to 4.09. Using the same 21 cent decrease for 2008, we arrive at EPS of 4.48 (4.69-.21). Multiplying the new EPS (4.48) by a conservative P/E of 19 we arrive at a price of $85.12.Why the P/E of 19? Amgen's current ttm P/E is 22. For the <a href="http://quicktake.morningstar.com/StockNet/Valuation10.aspx?Country=USA&Symbol=AMGN&stocktab=valuation ">past 10 years</a>, the P/E for Amgen has been as high as 60 and as low as 23. In conclusion, Amgen is still a bargain despite the recent events.
</p>]]>
      </content>
      <pubDate>Mon, 14 May 2007 04:28:16 -0400</pubDate>
      <author>Alex Garcia</author>
      <description>
        <![CDATA[strong><a href="http://wslounge.com/">Alex Garcia</a> submits: </strong>An FDA panel recommended stronger warning labels and further clinical studies on Amgen's (AMGN) Arenesp drug and Johnson and Johnson's (JNJ) Procrit drugs. <!--more-->In typical Wall Street fashion, shares of Amgen sold off on the recommendations. The clinical studies and new warning labels are sure to have impact on Amgen's top and bottom line. The question is how much impact? Analysts and sometimes the panel seemed confused about the whole situation. According to <a href="http://www.forbes.com/2007/05/11/amgen-fda-update-markets-equity-cx_er_0511markets19.html?partner=yahootix ">Forbes.com</a>, the panel asked several times "what was the question?" and the questions themselves were "vague". The shares of Amgen have now become very attractive despite the recent selloff.
<br />
<a href="http://finance.yahoo.com/q/pr?s=AMGN ">
<br />
Amgen Inc.</a>, a biotechnology company, engages in the discovery, development, manufacture, and marketing of human therapeutics based on advances in cellular and molecular biology. It markets human therapeutic products in the areas of supportive cancer care, nephrology, inflammation, and oncology worldwide. The company's principal products include Aranesp and EPOGEN that stimulate the production of red blood cells to treat anemia; Neulasta and NEUPOGEN, which selectively stimulate the production of neutrophils, a type of white blood cell that helps the body fight infections; ENBREL that blocks the biologic activity of tumor necrosis factor by inhibiting TNF, a substance induced in response to inflammatory and immunological responses, such as rheumatoid arthritis and psoriasis; Vectibix, which binds specifically to the human epidermal growth factor receptor and interferes with signals that stimulate growth and survival of the cancer cell; and Sensipar for treating chronic kidney disease patients on dialysis. Amgen has a joint venture with Kirin Brewery Company, Limited (KNBWY.PK), for the development and commercialization of products based on advanced biotechnology, as well as a co-promotion agreement with Wyeth (WYE) related to the manufacture, supply, inventory, and allocation of bulk supplies of ENBREL. The company also entered into a collaboration agreement with Cytokinetics, Inc. (CYTK) to discover, develop, and commercialize novel small-molecule therapeutics that activate cardiac muscle contractility for potential applications in the treatment of heart failure. Amgen, Inc. was founded in 1980 and is based in Thousand Oaks, California.  

<p>When evaluating a biotech company, one has to pay special attention to Research and Development (R&D) and its pipeline. According to its <a href="http://yahoo.brand.edgar-online.com/fetchFilingFrameset.aspx?dcn=0001193125-07-042586&Type=HTML ">recent annual report</a>, Amgen spent 3.36 billion on R&D, compared to 2.314 billion the prior year. The bears will argue that Amgen's pipeline is dry. But that argument is as old as the hills. Amgen's pipeline is one of the strongest, if not the strongest in the industry. Using three years of clinical data, Amgen plans to file for FDA approval in 2008 for denosumab in osteoporosis (Phase III).Denosumab will be the premier osteoporosis drug in the market once it is approved. Amgen is also on track to file for AMG 531 (Phase III), the treatment of immune thrombocytopenic purpura (a rare bleeding disorder). The filing is set for this year.In addition, A Phase III trial to prolong survival in prostate cancer patients whose cancer has spread to the bones during treatment is also ongoing.
</p>
<p>Lazard Capital analyst, Joel Sendek <a href="http://www.forbes.com/2007/05/11/amgen-fda-update-markets-equity-cx_er_0511markets19.html?partner=yahootix ">lowered 2007's EPS estimates</a> from 4.30 to 4.09. Using the same 21 cent decrease for 2008, we arrive at EPS of 4.48 (4.69-.21). Multiplying the new EPS (4.48) by a conservative P/E of 19 we arrive at a price of $85.12.Why the P/E of 19? Amgen's current ttm P/E is 22. For the <a href="http://quicktake.morningstar.com/StockNet/Valuation10.aspx?Country=USA&Symbol=AMGN&stocktab=valuation ">past 10 years</a>, the P/E for Amgen has been as high as 60 and as low as 23. In conclusion, Amgen is still a bargain despite the recent events.
</p><br/><a href='http://seekingalpha.com/article/35402-amgen-still-a-bargain-despite-recent-selloff?source=feed'>Complete Story &raquo;</a>]]>
      </description>
      <category type="symbol" link="http://seekingalpha.com/symbol/amgn">AMGN</category>
      <category type="author" link="http://seekingalpha.com/author/alex-garcia">Alex Garcia</category>
    </item>
    <item>
      <title>Homing in on WCI Communities</title>
      <link>http://seekingalpha.com/article/27292-homing-in-on-wci-communities?source=feed</link>
      <guid isPermaLink="false">27292</guid>
      <content>
        <![CDATA[After KB Homes (KBH) <a href="http://usmarket.seekingalpha.com/article/26939">reported</a> a horrible 4th quarter, I thought I would look around to see what was going on in the homebuilders.<!--more--> 

<p>Well, it didn’t take me long to find something interesting.
</p>
<p>The homebuilders companies are still suffering loses with CEOs seeing no end in sight. On the other hand, the stocks have kept going up despite companies' reporting. Two things might be causing this. First, the market is up substantially without any big dips and is simply carrying the homebuilders with them. Second, institutions are feeling the end is near and the housing sector might be headed for good times.
</p>]]>
      </content>
      <pubDate>Fri, 16 Feb 2007 06:33:59 -0500</pubDate>
      <author>Alex Garcia</author>
      <description>
        <![CDATA[strong><a href="http://wslounge.com/">Alex Garcia</a> submits: </strong>After KB Homes (KBH) <a href="http://usmarket.seekingalpha.com/article/26939">reported</a> a horrible 4th quarter, I thought I would look around to see what was going on in the homebuilders.<!--more--> 

<p>Well, it didn’t take me long to find something interesting.
</p>
<p>The homebuilders companies are still suffering loses with CEOs seeing no end in sight. On the other hand, the stocks have kept going up despite companies' reporting. Two things might be causing this. First, the market is up substantially without any big dips and is simply carrying the homebuilders with them. Second, institutions are feeling the end is near and the housing sector might be headed for good times.
</p><br/><a href='http://seekingalpha.com/article/27292-homing-in-on-wci-communities?source=feed'>Complete Story &raquo;</a>]]>
      </description>
      <category type="symbol" link="http://seekingalpha.com/symbol/kbh">KBH</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/wci">WCI</category>
      <category type="author" link="http://seekingalpha.com/author/alex-garcia">Alex Garcia</category>
    </item>
    <item>
      <title>Moving Bottom Up from the Heartland</title>
      <link>http://seekingalpha.com/article/26009-moving-bottom-up-from-the-heartland?source=feed</link>
      <guid isPermaLink="false">26009</guid>
      <content>
        <![CDATA[One thing that I love about Wall Street is the different approaches investors bring to the table.<!--more--> Each investor/trader believes that his system will beat the markets. 

<p>In my opinion, this is what makes Wall Street unique. Can you imagine every single investor buying low p/e stocks? There wouldn’t be any low p/e stocks around!
</p>
<p>Being a Contrarian Investor is going against the crowd and usually means going against what’s popular. But, what happens when the unpopular becomes popular? Let’s just say it is a good feeling.
</p>]]>
      </content>
      <pubDate>Mon, 05 Feb 2007 04:00:01 -0500</pubDate>
      <author>Alex Garcia</author>
      <description>
        <![CDATA[strong><a href="http://wslounge.com/">Alex Garcia</a> submits: </strong>One thing that I love about Wall Street is the different approaches investors bring to the table.<!--more--> Each investor/trader believes that his system will beat the markets. 

<p>In my opinion, this is what makes Wall Street unique. Can you imagine every single investor buying low p/e stocks? There wouldn’t be any low p/e stocks around!
</p>
<p>Being a Contrarian Investor is going against the crowd and usually means going against what’s popular. But, what happens when the unpopular becomes popular? Let’s just say it is a good feeling.
</p><br/><a href='http://seekingalpha.com/article/26009-moving-bottom-up-from-the-heartland?source=feed'>Complete Story &raquo;</a>]]>
      </description>
      <category type="symbol" link="http://seekingalpha.com/symbol/htld">HTLD</category>
      <category type="author" link="http://seekingalpha.com/author/alex-garcia">Alex Garcia</category>
    </item>
    <item>
      <title>BJ Services: The Company Behind the Oil Companies</title>
      <link>http://seekingalpha.com/article/24705-bj-services-the-company-behind-the-oil-companies?source=feed</link>
      <guid isPermaLink="false">24705</guid>
      <content>
        <![CDATA[Wall Street works in a funny way. The street is constantly reacting to events, ranging from earnings, economic data, the price of oil, a slowdown in housing, etc. So when one industry gets sold off, others affected by it follow suit.<!--more--> For example, in 2006, the homebuilders sold off as data indicated houses were not selling as quickly as they once were. Soon after, suppliers, hardware stores, construction machinery, cement, and other sectors followed suit. 

<p>After I wrote the article on <a href="http://energy.seekingalpha.com/article/24159">Conoco Phillips</a>, I looked around if anything interesting could be going on in other oil sectors and I was not disappointed. The company that I found and like is<strong> BJ Services</strong> (BJS). Here’s the company profile from <a href="http://finance.yahoo.com/q/pr?s=bjs">Yahoo Finance</a>: 
</p>
<blockquote class="quote"><p>BJ Services Company provides pressure pumping and other oilfield services for the petroleum industry worldwide. Its pressure pumping services consist of cementing and stimulation services used in the completion of new oil and natural gas wells, and in remedial work on existing wells both onshore and offshore. The cementing services comprise blending high-grade cement and water with various solid and liquid additives to create a cement slurry that is pumped into a well between the casing and the wellbore; and stimulation services include fracturing, acidizing, sand control, nitrogen services, coiled tubing, and service tools. The company also offers other oilfield services, including completion tools, completion fluids, casing and tubular services, and production chemical services, as well as precommissioning, maintenance, and turnaround services in the pipeline and process business, including pipeline inspection. Its customers include major and independent oil and natural gas producing companies, as well as national oil companies. BJ Services was founded in 1872 and is based in Houston, Texas.<br />
</p></blockquote>]]>
      </content>
      <pubDate>Mon, 22 Jan 2007 01:05:27 -0500</pubDate>
      <author>Alex Garcia</author>
      <description>
        <![CDATA[strong><a href="http://wslounge.com/">Alex Garcia</a> submits: </strong>Wall Street works in a funny way. The street is constantly reacting to events, ranging from earnings, economic data, the price of oil, a slowdown in housing, etc. So when one industry gets sold off, others affected by it follow suit.<!--more--> For example, in 2006, the homebuilders sold off as data indicated houses were not selling as quickly as they once were. Soon after, suppliers, hardware stores, construction machinery, cement, and other sectors followed suit. 

<p>After I wrote the article on <a href="http://energy.seekingalpha.com/article/24159">Conoco Phillips</a>, I looked around if anything interesting could be going on in other oil sectors and I was not disappointed. The company that I found and like is<strong> BJ Services</strong> (BJS). Here’s the company profile from <a href="http://finance.yahoo.com/q/pr?s=bjs">Yahoo Finance</a>: 
</p>
<blockquote class="quote"><p>BJ Services Company provides pressure pumping and other oilfield services for the petroleum industry worldwide. Its pressure pumping services consist of cementing and stimulation services used in the completion of new oil and natural gas wells, and in remedial work on existing wells both onshore and offshore. The cementing services comprise blending high-grade cement and water with various solid and liquid additives to create a cement slurry that is pumped into a well between the casing and the wellbore; and stimulation services include fracturing, acidizing, sand control, nitrogen services, coiled tubing, and service tools. The company also offers other oilfield services, including completion tools, completion fluids, casing and tubular services, and production chemical services, as well as precommissioning, maintenance, and turnaround services in the pipeline and process business, including pipeline inspection. Its customers include major and independent oil and natural gas producing companies, as well as national oil companies. BJ Services was founded in 1872 and is based in Houston, Texas.<br />
</p></blockquote><br/><a href='http://seekingalpha.com/article/24705-bj-services-the-company-behind-the-oil-companies?source=feed'>Complete Story &raquo;</a>]]>
      </description>
      <category type="symbol" link="http://seekingalpha.com/symbol/bjs">BJS</category>
      <category type="author" link="http://seekingalpha.com/author/alex-garcia">Alex Garcia</category>
    </item>
    <item>
      <title>Conoco Phillips: A Good Buy, Once Again</title>
      <link>http://seekingalpha.com/article/24159-conoco-phillips-a-good-buy-once-again?source=feed</link>
      <guid isPermaLink="false">24159</guid>
      <content>
        <![CDATA[This past week has been a hectic week, especially if you own an oil stock. The price per barrel has headed south and has taken oil stocks down with it. The company that I love here is Conoco Phillips (COP).<!--more-->

<p> Here’s the company profile from <a href="http://finance.yahoo.com/q/pr?s=COP">Yahoo Finance</a>:
</p>
<p><img title="cp logo" src="http://static.seekingalpha.com/wp-content/seekingalpha/images/cplogo.jpg" border="0" vspace="6" height="90" hspace="7" alt="cp logo" align="right" width="116" />
</p>]]>
      </content>
      <pubDate>Sun, 14 Jan 2007 15:40:16 -0500</pubDate>
      <author>Alex Garcia</author>
      <description>
        <![CDATA[strong><a href="http://wslounge.com/">Alex Garcia</a> submits: </strong>This past week has been a hectic week, especially if you own an oil stock. The price per barrel has headed south and has taken oil stocks down with it. The company that I love here is Conoco Phillips (COP).<!--more-->

<p> Here’s the company profile from <a href="http://finance.yahoo.com/q/pr?s=COP">Yahoo Finance</a>:
</p>
<p><img title="cp logo" src="http://static.seekingalpha.com/wp-content/seekingalpha/images/cplogo.jpg" border="0" vspace="6" height="90" hspace="7" alt="cp logo" align="right" width="116" />
</p><br/><a href='http://seekingalpha.com/article/24159-conoco-phillips-a-good-buy-once-again?source=feed'>Complete Story &raquo;</a>]]>
      </description>
      <category type="symbol" link="http://seekingalpha.com/symbol/cop">COP</category>
      <category type="author" link="http://seekingalpha.com/author/alex-garcia">Alex Garcia</category>
    </item>
    <item>
      <title>Home Depot Investors Bought High: Unfortunately, The "Fool" Didn't Buy Higher</title>
      <link>http://seekingalpha.com/article/23452-home-depot-investors-bought-high-unfortunately-the-fool-didn-t-buy-higher?source=feed</link>
      <guid isPermaLink="false">23452</guid>
      <content>
        <![CDATA[Yesterday, <a href="http://wslounge.com/2006/12/22/home-depot-hd/">Home Depot</a> (HD) shareholders received the <a href="http://www.marketwatch.com/news/story/home-depot-chief-nardelli-resigns/story.aspx?guid=%7B66FE1A6C%2D9057%2D4A4E%2D9200%2DE6BC2BCACA66%7D&siteid=yhoo&dist=yhoo">news</a> they have been waiting for: the resignation of now ex-CEO Robert Nardelli. Nardelli has been under immense pressure from shareholders after exercising options and the stock price not going anywhere. I understand the anger over the exercised options but whose fault is it that the share price has gone nowhere?<!--more-->

<p>First lets check out Home Depot’s numbers since Nardelli took over in 2000. <a href="http://quicktake.morningstar.com/Stock/Income10.asp?Country=USA&Symbol=HD&stocktab=finance">Revenues</a> have nearly doubled from 45 billion to 81 billion. <a href="http://quicktake.morningstar.com/Stock/Income10.asp?Country=USA&Symbol=HD&stocktab=finance">Earnings</a> have more than doubled from 1.00/share to 2.72/share. <a href="http://quicktake.morningstar.com/Stock/Profitability10.asp?Country=USA&Symbol=HD&stocktab=keyratio">Return on equity</a> has held steady at 18-22%. <a href="http://quicktake.morningstar.com/Stock/Profitability10.asp?Country=USA&Symbol=HD&stocktab=keyratio">Return on assets</a> have also stayed steady in the 12-15 percentiles. Gross margins have also increased steadily from 29.7% to 33.4%. Everything looks fine, so “what’s up doc?”
</p>
<p>The answer is quite simple; investors bought high. The P/E for Home Depot in 2000 is a startling <a href="http://quicktake.morningstar.com/Stock/Valuation10.asp?Country=USA&Symbol=HD&stocktab=valuation">56</a>. Investors quite frankly bought on the fools theory. The fools’ theory tells us to buy high and sell to a “fool” higher. In this case the fool never bought higher.
</p>]]>
      </content>
      <pubDate>Thu, 04 Jan 2007 06:23:01 -0500</pubDate>
      <author>Alex Garcia</author>
      <description>
        <![CDATA[strong><a href="http://wslounge.com/">Alex Garcia</a> submits: </strong>Yesterday, <a href="http://wslounge.com/2006/12/22/home-depot-hd/">Home Depot</a> (HD) shareholders received the <a href="http://www.marketwatch.com/news/story/home-depot-chief-nardelli-resigns/story.aspx?guid=%7B66FE1A6C%2D9057%2D4A4E%2D9200%2DE6BC2BCACA66%7D&siteid=yhoo&dist=yhoo">news</a> they have been waiting for: the resignation of now ex-CEO Robert Nardelli. Nardelli has been under immense pressure from shareholders after exercising options and the stock price not going anywhere. I understand the anger over the exercised options but whose fault is it that the share price has gone nowhere?<!--more-->

<p>First lets check out Home Depot’s numbers since Nardelli took over in 2000. <a href="http://quicktake.morningstar.com/Stock/Income10.asp?Country=USA&Symbol=HD&stocktab=finance">Revenues</a> have nearly doubled from 45 billion to 81 billion. <a href="http://quicktake.morningstar.com/Stock/Income10.asp?Country=USA&Symbol=HD&stocktab=finance">Earnings</a> have more than doubled from 1.00/share to 2.72/share. <a href="http://quicktake.morningstar.com/Stock/Profitability10.asp?Country=USA&Symbol=HD&stocktab=keyratio">Return on equity</a> has held steady at 18-22%. <a href="http://quicktake.morningstar.com/Stock/Profitability10.asp?Country=USA&Symbol=HD&stocktab=keyratio">Return on assets</a> have also stayed steady in the 12-15 percentiles. Gross margins have also increased steadily from 29.7% to 33.4%. Everything looks fine, so “what’s up doc?”
</p>
<p>The answer is quite simple; investors bought high. The P/E for Home Depot in 2000 is a startling <a href="http://quicktake.morningstar.com/Stock/Valuation10.asp?Country=USA&Symbol=HD&stocktab=valuation">56</a>. Investors quite frankly bought on the fools theory. The fools’ theory tells us to buy high and sell to a “fool” higher. In this case the fool never bought higher.
</p><br/><a href='http://seekingalpha.com/article/23452-home-depot-investors-bought-high-unfortunately-the-fool-didn-t-buy-higher?source=feed'>Complete Story &raquo;</a>]]>
      </description>
      <category type="symbol" link="http://seekingalpha.com/symbol/hd">HD</category>
      <category type="author" link="http://seekingalpha.com/author/alex-garcia">Alex Garcia</category>
    </item>
    <item>
      <title>Sears Holdings: A Baby Berkshire in the Making?</title>
      <link>http://seekingalpha.com/article/23299-sears-holdings-a-baby-berkshire-in-the-making?source=feed</link>
      <guid isPermaLink="false">23299</guid>
      <content>
        <![CDATA[Last semester my history teacher and I used to stay after class and discuss the market. She asked me, about one month ago, what stock I like right now, and I mentioned Sears. <!--more--> Her reaction was not one that I had hoped for. 

<p>It struck me right away that she was not up to date with what was going on at Sears Holdings (SHLD). She had the picture of a struggling American icon. I had the vision of a baby Berkshire Hathaway (BRK.A).
</p>
<p>Sears Holdings was created when Kmart Holding Corp. acquired Sears Roebuck, thus creating Sears Holdings Corp. Both Kmart and Sears have been around since the late 19th century and both struggled in the latter half of the 20th century as Wal-Mart (WMT) expanded.
</p>]]>
      </content>
      <pubDate>Tue, 02 Jan 2007 10:29:34 -0500</pubDate>
      <author>Alex Garcia</author>
      <description>
        <![CDATA[strong><a href="http://wslounge.com/">Alex Garcia</a> submits: </strong>Last semester my history teacher and I used to stay after class and discuss the market. She asked me, about one month ago, what stock I like right now, and I mentioned Sears. <!--more--> Her reaction was not one that I had hoped for. 

<p>It struck me right away that she was not up to date with what was going on at Sears Holdings (SHLD). She had the picture of a struggling American icon. I had the vision of a baby Berkshire Hathaway (BRK.A).
</p>
<p>Sears Holdings was created when Kmart Holding Corp. acquired Sears Roebuck, thus creating Sears Holdings Corp. Both Kmart and Sears have been around since the late 19th century and both struggled in the latter half of the 20th century as Wal-Mart (WMT) expanded.
</p><br/><a href='http://seekingalpha.com/article/23299-sears-holdings-a-baby-berkshire-in-the-making?source=feed'>Complete Story &raquo;</a>]]>
      </description>
      <category type="symbol" link="http://seekingalpha.com/symbol/shld">SHLD</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/wmt">WMT</category>
      <category type="author" link="http://seekingalpha.com/author/alex-garcia">Alex Garcia</category>
    </item>
    <item>
      <title>Heartland Inc.: The Trucking Company With a Heart of Gold</title>
      <link>http://seekingalpha.com/article/23232-heartland-inc-the-trucking-company-with-a-heart-of-gold?source=feed</link>
      <guid isPermaLink="false">23232</guid>
      <content>
        <![CDATA[As the country heads into an economic slowdown, the street is selling those industries that might be affected the worst. The trucking industry is one of those industries. The trucking industry is down 17.57% the past 6 months and 5.78% the past 3 months.The industry selloff has caused companies in the industry to trade around 52-week lows. My favorite in the industry is <strong>Heartland Express Inc. (HTLD)</strong>.<!--more-->

<p>The Company is a short-to-medium haul truckload carrier based in Iowa. The company provides nationwide transportation service to major shippers. and it mainly operates east of the Rocky Mountains, hence the name Heartland. Its average distance for shipments is 523 miles. Think of Heartland as the <strong>Southwest Airlines (LUV)</strong> of the trucking industry before Southwest went nationwide.
</p>
<p>The company’s president is Russell Gerdin. He has held that post since 1978 and chairman of the board since 1986. In an era when CEO’s are being fired at a rapid pace Heartland has shown stability. Russell’s compensation is at a modest 300K.
</p>]]>
      </content>
      <pubDate>Fri, 29 Dec 2006 06:35:31 -0500</pubDate>
      <author>Alex Garcia</author>
      <description>
        <![CDATA[strong><a href="http://wslounge.com/">Alex Garcia</a> submits: </strong>As the country heads into an economic slowdown, the street is selling those industries that might be affected the worst. The trucking industry is one of those industries. The trucking industry is down 17.57% the past 6 months and 5.78% the past 3 months.The industry selloff has caused companies in the industry to trade around 52-week lows. My favorite in the industry is <strong>Heartland Express Inc. (HTLD)</strong>.<!--more-->

<p>The Company is a short-to-medium haul truckload carrier based in Iowa. The company provides nationwide transportation service to major shippers. and it mainly operates east of the Rocky Mountains, hence the name Heartland. Its average distance for shipments is 523 miles. Think of Heartland as the <strong>Southwest Airlines (LUV)</strong> of the trucking industry before Southwest went nationwide.
</p>
<p>The company’s president is Russell Gerdin. He has held that post since 1978 and chairman of the board since 1986. In an era when CEO’s are being fired at a rapid pace Heartland has shown stability. Russell’s compensation is at a modest 300K.
</p><br/><a href='http://seekingalpha.com/article/23232-heartland-inc-the-trucking-company-with-a-heart-of-gold?source=feed'>Complete Story &raquo;</a>]]>
      </description>
      <category type="symbol" link="http://seekingalpha.com/symbol/htld">HTLD</category>
      <category type="author" link="http://seekingalpha.com/author/alex-garcia">Alex Garcia</category>
    </item>
  </channel>
</rss>
